Global Pharmaceutical IT Spending Forecast through 2013 (Market Model)

Datamonitor, September 2008

As pharmaceutical and biotechnology companies increasingly turn to IT to reduce costs and time-to-market of a drug, it is important for technology vendors to understand where growth opportunities exist in the global life science market. This model will provide a forecast and analysis of IT spending in the pharma/biotech industries through 2013.

Key reasons to purchase this title

- Understand the opportunity size for technology spending in the global life science market

- Identify potential areas for spending growth amongst pharmaceutical and biotechnology companies

- Segment the life science industry by spending opportunities

Customers who bought this item also bought

• PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013
• Pharmaceutical Outsourcing in Drug Discovery and Development: Contract Research Opportunity in India
• Laboratory Information Management Systems (LIMS) - Global Outlook
• The 2012 Healthcare Business Market Research Handbook
• Chemotherapy Effects – Pipeline Review, H1 2013
• The Neurotechnology Industry 2012 Report
• Laboratory Automation - Global Outlook
• Maven Semantic Healthcare Database (SME Package)
• BioMEMS 2013: Microsystem Device Market for Healthcare Applications
• The Developing Life Sciences Industries of China and India